Spring direct naar de hoofdnavigatie of de inhoud
‘Optimally capitalize on your innovation. Activate your ideas.’
Kaat Schroven

Kaat Schroven

  • Life Sciences
  • Trainee Patent Attorney

After her education in Bioscience Engineering with a major in cellular and genetic engineering, Kaat started her PhD at the Lab of Gene Technology (KU Leuven). During her PhD project, she investigated the potential of bacteriophage-derived proteins as anti-virulence compounds.

Continue reading

Kaat is specialized in among others microbiology, genome technology and synthetic biology.

Education

  • PhD in Bioscience engineering – KU Leuven (2019-2023)
  • MSc in Bioscience engineering, cellular and genetic engineering  – KU Leuven (2017-2019)
  • BSc in Bioscience engineering – KU Leuven (2014-2017)

Publications

  • Lammens E-M, Volke DC, Schroven K, Voet M, Kerremans A, Lavigne R, Hendrix H. A SEVA-based, CRISPR-Cas3-assisted genome engineering approach for Pseudomonas with efficient vector curing. Microbiol Spectr. 2023 Dec 12;11(6):e0270723. doi: 10.1128/spectrum.02707-23. Epub 2023 Nov 17. PMID: 37975669; PMCID: PMC10715078.
  • Schroven K, Putzeys L, Kerremans A, Ceyssens P-J, Vallino M, Paeshuyse J, Haque F, Yusuf A, Koch MD, Lavigne R. The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa. Microbiol Spectr. 2023 Dec 12;11(6):e0237223. doi: 10.1128/spectrum.02372-23. Epub 2023 Nov 14. PMID: 37962408; PMCID: PMC10714779.
  • Schroven K, Putzeys L, Swinnen AL, Hendrix H, Paeshuyse J, Lavigne R. The phage-encoded protein PIT2 impacts Pseudomonas aeruginosa quorum sensing by direct interaction with LasR. iScience. 2023 Aug 26;26(10):107745. doi: 10.1016/j.isci.2023.107745. PMID: 37736037; PMCID: PMC10509696.
  • Van Nieuwenhuyse, B., Van der Linden, D., Chatzis, O., Lood, C., Wagemans J., Lavigne R., Schroven K., Paeshuyse J., de Magnée C., Sokal, E., Stéphenne, X., Scheers, I., Rodriguez-Villalobos, H., Djebara, S., Merabishvili, M., Soentjes, ., Pirnay, JP. Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler. Nat Commun 13, 5725 (2022). https://doi.org/10.1038/s41467-022-33294-w
  • Schroven K., Aertsen, A., Lavigne, R. Bacteriophages as drivers of bacterial virulence and their potential for biotechnological exploitation, FEMS Microbiology Reviews, Volume 45, Issue 1, January 2021, fuaa041, https://doi.org/10.1093/femsre/fuaa041

Languages

  • Dutch (native)
  • English (fluent)
  • French (basic)

Also see these experts

Sjoerd Postma

Sjoerd Postma

  • European and Dutch Patent Attorney, European Patent Litigator
  • Associate
Jetze Beeksma

Jetze Beeksma

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
More experts

News

Ten-day rule abolished

Since 1 November 2023, the European Patent Office (EPO) has abolished the so-called “ten-day rule”. According to that rule, a letter sent by the EPO was deemed to be delivered ten days after its date, which allowed the deadline for reply to be extended by ten days.Continue reading

Student competitions started again

The annual innovation competitions of several Dutch universities have recently started up again: the TU Delft Impact Contest, the TU/e Contest, the Erasmus University Contest, the UT Entrepreneurial Challenge and the UvA EB Challenge.Continue reading

Voice Over?

Videotapes, cassette tapes, CDs; in the world of image and sound carriers, you can suddenly lose your business due to technical developments. True, tapes and vinyl are on the rise again, but there are also still “victims.”Continue reading

Events

BIO International Convention 2024

San Diego Convention Center, Harbor Drive, San Diego, San Diego, CA, USA

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.

Continue reading